ProQuest has acquired U.K.-based Pi2 Solutions, provider of product literature databases, workflow tools, and related outsourcing services for global pharmaceutical companies. The company plans to align Pi2 with its ProQuest Dialog corporate information service to create an integrated solution for pharmacovigilance and expand ProQuest's presence in the pharmaceutical industry.
Pharmaceutical companies use ProQuest Dialog to monitor scientific literature for advances and news on drugs and therapies through alerts. They can now use Pi2's Drug Safety Triager and related services to automate the review, categorization, and indexing of alert results. These results then flow into Pi2's PinPoint product - a customized repository that offers search and content management functionality and delivers necessary regulatory reports.
Many pharmaceutical firms have developed very customized solutions, so ProQuest Dialog will continue to feed alerts to other providers of product literature databases and Pi2 will continue to ingest alerts from other aggregators. ProQuest will maintain partnerships and connectivity with all the content and software providers that its customers use to support their processes.